We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01596751
First Posted: May 11, 2012
Last Update Posted: August 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Susan G. Komen Breast Cancer Foundation
Plexxikon
Information provided by (Responsible Party):
Hope Rugo, MD, University of California, San Francisco
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2020
  Primary Completion Date: February 28, 2017 (Final data collection date for primary outcome measure)